Dexcom (DXCM) Total Non-Current Liabilities (2010 - 2026)
Dexcom (DXCM) posted quarterly Total Non-Current Liabilities of $3.7 billion for Q2 2026, down 19.97% year-over-year from $4.6 billion in Q2 2025, and up 4.2% quarter-over-quarter from $3.5 billion in Q1 2026.
Dexcom (DXCM) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.7 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 19.97% year-over-year to $3.7 billion; the TTM figure through Jun 2026 stood at $3.7 billion (down 19.97% YoY), while the FY2025 annual figure was $3.5 billion, down 18.36% from the prior year.
- Total Non-Current Liabilities improved to $3.7 billion in Q2 2026 per DXCM's latest filing, from $3.5 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $4.6 billion in Q3 2025 and bottomed at $2.8 billion in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $3.8 billion across 5 years, with a median of $4.1 billion in 2023.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 60.28% — and 2026, when it decreased 19.97%.
- Dexcom's Total Non-Current Liabilities stood at $3.1 billion in 2022, then gained by 29.98% to $4.1 billion in 2023, then increased by 4.02% to $4.2 billion in 2024, then declined by 18.36% to $3.5 billion in 2025, then grew by 6.55% to $3.7 billion in 2026.
- Business Quant data shows DXCM's Total Non-Current Liabilities at $3.7 billion in Q2 2026, $3.5 billion in Q1 2026, and $3.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.68 Bn |
| Mar 31, 2026 | 3.53 Bn |
| Dec 31, 2025 | 3.46 Bn |
| Sep 30, 2025 | 4.63 Bn |
| Jun 30, 2025 | 4.60 Bn |
| Mar 31, 2025 | 4.33 Bn |
| Dec 31, 2024 | 4.23 Bn |
| Sep 30, 2024 | 4.25 Bn |
| Jun 30, 2024 | 4.24 Bn |
| Mar 31, 2024 | 4.11 Bn |
| Dec 31, 2023 | 4.07 Bn |
| Sep 30, 2023 | 4.19 Bn |
| Jun 30, 2023 | 4.59 Bn |
| Mar 31, 2023 | 3.15 Bn |
| Dec 31, 2022 | 3.13 Bn |
| Sep 30, 2022 | 2.95 Bn |
| Jun 30, 2022 | 2.86 Bn |
| Mar 31, 2022 | 2.77 Bn |
| Dec 31, 2021 | 2.80 Bn |
| Sep 30, 2021 | 2.54 Bn |